CCL2 and Insulin resistance: This is likely due to (1) increased WAT expression of adiponectin, a beneficial adipokine that sensitizes the body to insulin24, (2) decreased inflammation in WATs as evidenced by decreased expression of TNFα, a cytokine that promotes insulin resistance, and decreased CCL2 protein levels in eWAT, and (3) decreased fibrosis in WATs.